EpiCast: Osteoporosis Epidemiology Forecast to 2022

Feb. 1, 2013 - PRLog -- The climbing elderly populations of India and China will lead to a surge in the number of prevalent cases of osteoporosis in the following decade, predicts the latest report from research and consulting firm GlobalData.

The company’s new epidemiology report* forecasts that osteoporosis prevalence in China is set to jump from 50.3 million cases in 2012 to 68.4 million cases in 2022, representing an Annual Growth Rate (AGR) of 3.6%. Similarly, India’s prevalent osteoporosis population is expected to climb from 55 million in 2012 to hit 73.8 million a decade later, at an AGR of 3.4%.

According to GlobalData, the expanding populations of these countries, particularly within the higher age categories, are key contributors to this surge in prevalent cases of osteoporosis – particularly as the age of onset seems to be earlier in these two nations than in many other countries.

For Sample Pages, please click or add the below link to your browser:

http://store.globaldata.com/market-reports/pharmaceuticals-and-healthcare/EpiCast-Osteoporosis-Epidemiology-Forecast-to-2022/sample&CompanyID=prlog

To date, osteoporosis has not been recognized as a major health burden in China or India. While disease prevention and treatment have improved over the last two decades, public awareness of osteoporosis remains minimal, particularly in rural areas.

This report provides an overview of the risk factors and global trends of osteoporosis in seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging markets—India and China.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

GlobalData is a leading global research and consulting firm offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For further details, please click or add the below link to your browser:

http://store.globaldata.com/market-reports/pharmaceuticals-and-healthcare/EpiCast-Osteoporosis-Epidemiology-Forecast-to-2022&CompanyID=prlog (http://store.globaldata.com/market-reports/pharmaceutical...)

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:

pressreleases@globaldata.com

North America:          +1 646 395 5477

Europe:          +44 207 753 4299

         +44 1204 543 533

Asia Pacific:          +91 40 6616 6782